NZ197573A - 7-(2-(aminothiazolyl)-2-(alkoxy-or hydroxy-imino)-acetamido)-3-(tetrazolylthiomethyl)-cephalosporins and pharmaceutical compositions - Google Patents
7-(2-(aminothiazolyl)-2-(alkoxy-or hydroxy-imino)-acetamido)-3-(tetrazolylthiomethyl)-cephalosporins and pharmaceutical compositionsInfo
- Publication number
- NZ197573A NZ197573A NZ197573A NZ19757381A NZ197573A NZ 197573 A NZ197573 A NZ 197573A NZ 197573 A NZ197573 A NZ 197573A NZ 19757381 A NZ19757381 A NZ 19757381A NZ 197573 A NZ197573 A NZ 197573A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- hydrogen
- formula
- cooh
- compound according
- Prior art date
Links
- -1 hydroxy-imino Chemical group 0.000 title claims description 14
- 229940124587 cephalosporin Drugs 0.000 title claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 12
- 229930186147 Cephalosporin Natural products 0.000 claims description 11
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 5
- 125000006239 protecting group Chemical group 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 208000035143 Bacterial infection Diseases 0.000 claims description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 description 8
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 8
- 150000001780 cephalosporins Chemical class 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 description 5
- 229960003012 cefamandole Drugs 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- QITDACOZCQXYQY-BAFYGKSASA-N (6r)-7-amino-5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one Chemical class S1CC=CN2C(=O)C(N)[C@H]21 QITDACOZCQXYQY-BAFYGKSASA-N 0.000 description 1
- IKWLIQXIPRUIDU-ZCFIWIBFSA-N (6r)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=CCS[C@@H]2CC(=O)N12 IKWLIQXIPRUIDU-ZCFIWIBFSA-N 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- HPVYMSBZIOPTKS-UHFFFAOYSA-N 1,2-dihydrotetrazole-5-thione;sodium Chemical compound [Na].[Na].S=C1N=NNN1 HPVYMSBZIOPTKS-UHFFFAOYSA-N 0.000 description 1
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical compound SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588772 Morganella morganii Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical group NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000004964 sulfoalkyl group Chemical group 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 150000003536 tetrazoles Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/165,822 US4308267A (en) | 1980-07-03 | 1980-07-03 | 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ197573A true NZ197573A (en) | 1984-09-28 |
Family
ID=22600626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ197573A NZ197573A (en) | 1980-07-03 | 1981-06-30 | 7-(2-(aminothiazolyl)-2-(alkoxy-or hydroxy-imino)-acetamido)-3-(tetrazolylthiomethyl)-cephalosporins and pharmaceutical compositions |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4308267A (enExample) |
| EP (1) | EP0043713B1 (enExample) |
| JP (1) | JPS5745189A (enExample) |
| KR (1) | KR840002046B1 (enExample) |
| AR (1) | AR228606A1 (enExample) |
| AT (1) | ATE9585T1 (enExample) |
| AU (1) | AU547942B2 (enExample) |
| CA (1) | CA1151150A (enExample) |
| DE (1) | DE3166321D1 (enExample) |
| DK (1) | DK286981A (enExample) |
| ES (1) | ES503622A0 (enExample) |
| FI (1) | FI66876C (enExample) |
| GR (1) | GR74363B (enExample) |
| HU (1) | HU185934B (enExample) |
| IE (1) | IE51365B1 (enExample) |
| IL (1) | IL63206A (enExample) |
| NO (1) | NO812268L (enExample) |
| NZ (1) | NZ197573A (enExample) |
| PH (1) | PH17670A (enExample) |
| PT (1) | PT73292B (enExample) |
| YU (1) | YU162481A (enExample) |
| ZA (1) | ZA814484B (enExample) |
| ZW (1) | ZW15181A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526977A (en) * | 1981-10-07 | 1985-07-02 | American Home Products Corporation | 2-(3-Amino-5-isoxazolyl)-2-oxyimino-acetic acids |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4171362A (en) * | 1975-10-30 | 1979-10-16 | Smithkline Corporation | 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them |
| DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| JPS52125188A (en) | 1976-04-14 | 1977-10-20 | Takeda Chem Ind Ltd | Cephalosporin derivatives and their preparation |
| US4066762A (en) * | 1976-07-12 | 1978-01-03 | Smithkline Corporation | Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| MC1259A1 (fr) | 1978-05-30 | 1980-01-14 | Hoffmann La Roche | Derives acyles |
| US4220761A (en) * | 1978-09-12 | 1980-09-02 | Fujisawa Pharmaceutical Co., Ltd. | 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives |
-
1980
- 1980-07-03 US US06/165,822 patent/US4308267A/en not_active Expired - Lifetime
-
1981
- 1981-06-29 AU AU72343/81A patent/AU547942B2/en not_active Ceased
- 1981-06-29 CA CA000380845A patent/CA1151150A/en not_active Expired
- 1981-06-29 JP JP56102168A patent/JPS5745189A/ja active Pending
- 1981-06-29 DK DK286981A patent/DK286981A/da not_active Application Discontinuation
- 1981-06-29 IL IL63206A patent/IL63206A/xx unknown
- 1981-06-30 YU YU01624/81A patent/YU162481A/xx unknown
- 1981-06-30 FI FI812046A patent/FI66876C/fi not_active IP Right Cessation
- 1981-06-30 PT PT73292A patent/PT73292B/pt unknown
- 1981-06-30 PH PH25836A patent/PH17670A/en unknown
- 1981-06-30 NZ NZ197573A patent/NZ197573A/en unknown
- 1981-06-30 GR GR65386A patent/GR74363B/el unknown
- 1981-07-01 ZW ZW151/81A patent/ZW15181A1/xx unknown
- 1981-07-02 ZA ZA814484A patent/ZA814484B/xx unknown
- 1981-07-02 NO NO812268A patent/NO812268L/no unknown
- 1981-07-02 IE IE1481/81A patent/IE51365B1/en unknown
- 1981-07-02 HU HU811934A patent/HU185934B/hu unknown
- 1981-07-02 ES ES503622A patent/ES503622A0/es active Granted
- 1981-07-02 KR KR1019810002403A patent/KR840002046B1/ko not_active Expired
- 1981-07-03 DE DE8181303044T patent/DE3166321D1/de not_active Expired
- 1981-07-03 AT AT81303044T patent/ATE9585T1/de not_active IP Right Cessation
- 1981-07-03 EP EP81303044A patent/EP0043713B1/en not_active Expired
- 1981-07-03 AR AR285975A patent/AR228606A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| AR228606A1 (es) | 1983-03-30 |
| YU162481A (en) | 1983-06-30 |
| NO812268L (no) | 1982-01-04 |
| GR74363B (enExample) | 1984-06-28 |
| FI66876B (fi) | 1984-08-31 |
| DK286981A (da) | 1982-01-04 |
| AU7234381A (en) | 1982-01-07 |
| IE51365B1 (en) | 1986-12-10 |
| EP0043713A1 (en) | 1982-01-13 |
| IE811481L (en) | 1982-01-03 |
| PT73292B (en) | 1982-07-22 |
| HU185934B (en) | 1985-04-28 |
| AU547942B2 (en) | 1985-11-14 |
| EP0043713B1 (en) | 1984-09-26 |
| ZA814484B (en) | 1982-07-28 |
| ATE9585T1 (de) | 1984-10-15 |
| IL63206A (en) | 1986-09-30 |
| FI812046L (fi) | 1982-01-04 |
| KR830006310A (ko) | 1983-09-20 |
| PT73292A (en) | 1981-07-01 |
| ZW15181A1 (en) | 1981-09-29 |
| ES8203908A1 (es) | 1982-04-01 |
| PH17670A (en) | 1984-11-02 |
| DE3166321D1 (en) | 1984-10-31 |
| ES503622A0 (es) | 1982-04-01 |
| IL63206A0 (en) | 1981-09-13 |
| FI66876C (fi) | 1984-12-10 |
| JPS5745189A (en) | 1982-03-13 |
| CA1151150A (en) | 1983-08-02 |
| US4308267A (en) | 1981-12-29 |
| KR840002046B1 (ko) | 1984-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4839350A (en) | Cephalosporin compounds and the production thereof | |
| JPS59172493A (ja) | 化合物 | |
| GB2132613A (en) | 7-carboxymethoxyphenylacetamido-3-cephem derivatives processes for the preparation thereof and antibacterial preparations containing the same | |
| US3766175A (en) | Certain 7 - (o-aminomethylphenylacetamido) - 3-((heterocyclylthio)methyl)ceph-3-em-4-carboxylic acids | |
| NO874690L (no) | Fremgangsmaate for fremstilling av antibakterielle cefalosporiner. | |
| CS204957B2 (en) | Method of producing novel 7-2-/4-thiazolyl/-2-iminoacetamido-3-/4-alkyl-5-oxo-6-hydroxy-4,5-dihydro-1,2,4-triazin-3-ylthio/methyl-3-cephemderivatives | |
| AU628060B2 (en) | Cephalosporin antibiotics DO NOT SEAL CASE WITHDRAWN | |
| US4604387A (en) | 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, and a procedure for their preparation | |
| NZ197573A (en) | 7-(2-(aminothiazolyl)-2-(alkoxy-or hydroxy-imino)-acetamido)-3-(tetrazolylthiomethyl)-cephalosporins and pharmaceutical compositions | |
| JPH04225985A (ja) | セフアロスポリン化合物 | |
| EP0449515A2 (en) | Novel cephalosporin intermediates and process for preparing the intermediates and their end products | |
| PL132054B1 (en) | Process for preparing novel derivatives of cephalosporins substituted in position 3 with heterocyclothiomethyl group | |
| SK279280B6 (sk) | Spôsob výroby hemiheptahydrátu dvojsodnej soli 7-[ | |
| JP2000514832A (ja) | 抗菌性の置換７−アシルアミノ−３−（メチルヒドラゾノ）メチルセファロスポリンおよび中間体 | |
| JPS62167784A (ja) | 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤 | |
| US4058609A (en) | 7-Dithioacetamido cephalosporins | |
| JP3041309B2 (ja) | ３―置換ビニルセファロスポリン誘導体 | |
| JPS60231683A (ja) | セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤 | |
| GB2123414A (en) | Cephalosporin antibiotics | |
| JPS6197290A (ja) | セフアロスポリン誘導体その製造法およびそれを有効成分とする抗菌剤 | |
| JP2959821B2 (ja) | チアゾリルアセトアミドセフェム誘導体 | |
| GB2132193A (en) | Cephalosporin antibiotics | |
| JP3005273B2 (ja) | チアゾリルアセトアミド―３―セフェム系誘導体 | |
| JPH042596B2 (enExample) | ||
| JPS61286389A (ja) | セフエム系化合物 |